What is NDC 70518-4663?

70518-4663 is the product NDC for Oxcarbazepine, Oxcarbazepine 300 mg/1 tablet, film coated, listed with the FDA by REMEDYREPACK INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.

REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Oxcarbazepine?

118 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Oxcarbazepine NDC 70518-4663 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4663Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4663Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-4663-0	70518466300	30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4663-0)Marketed from May 18, 2026
70518-4663-1	70518466301	100 POUCH in 1 BOX (70518-4663-1) / 1 TABLET, FILM COATED in 1 POUCH (70518-4663-2)Marketed from Jun 7, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxcarbazepine
Generic name (nonproprietary): oxcarbazepine
Active ingredients: Oxcarbazepine — 300 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: REMEDYREPACK INC.NDC labeler code 70518
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078069
Marketing start: May 18, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 70518-4663_53bcc342-2571-4636-e063-6294a90ad7c6SPL ID 53bcc342-2571-4636-e063-6294a90ad7c6SPL set ID fcf5044a-8cfd-47d5-9f47-8f6674843c24RxCUI 312137UNII VZI5B1W380
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518466300 followed by a unit qualifier and the quantity

Package 70518-4663-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 8, 2026.

Indications (excerpt from the label)

Oxcarbazepine tablets are indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures. Oxcarbazepine tablets are indicated for: Adults: Monotherapy or adjunctive therapy in the treatment of partial-onset seizures Pediatrics: Monotherapy in the treatment of partial-onset seizures in children 4–16 years Adjunctive therapy in the treatment of partial-onset seizures in children 2–16 years ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70518-4663

What is NDC 70518-4663?: 70518-4663 is the product NDC for Oxcarbazepine, Oxcarbazepine 300 mg/1 tablet, film coated, listed with the FDA by REMEDYREPACK INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Oxcarbazepine.
What is the active ingredient?: Oxcarbazepine.
Who is the labeler?: REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Oxcarbazepine?: 118 other product NDCs are listed under this name. See all Oxcarbazepine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Oxcarbazepine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-172	90096-0172-01
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-171	90096-0171-01
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-173	90096-0173-01
Oxcarbazepine	Oxcarbazepine 300 mg/5mL	SuspensionOral	Novadoz Pharmaceuticals LLC	72205-354	72205-0354-85
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4664	70518-4664-0070518-4664-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-2084	67046-2084-03
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0868	67046-0868-03
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0179	67046-0179-03
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7593	00904-7593-61
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7594	00904-7594-61

All 119 Oxcarbazepine NDCs

Other NDCs under ANDA 078069

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078069
Product	Strength	Form · route	Labeler	Product NDC
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-4320
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-4323
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7593
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-2370
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7594
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7595
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-9186
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-6834
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-1597
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-0090
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	72162-1594
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7262
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7263
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-7866
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7264
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4664
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Breckenridge Pharmaceutical, Inc.	51991-054
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Breckenridge Pharmaceutical, Inc.	51991-053
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Breckenridge Pharmaceutical, Inc.	51991-055
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Breckenridge Pharmaceutical, Inc.	51991-292

Showing 20 of 31.